Targeting FGFR2 Fusion in ICC: Oligonucleotide and Metabolic
2026-04-24
This study introduces a cholesterol-conjugated DNA/RNA heteroduplex oligonucleotide (Cho-HDO) specifically targeting FGFR2-AHCYL1 fusion in intrahepatic cholangiocarcinoma (ICC). The combination of targeted posttranscriptional inhibition with asparagine depletion demonstrates enhanced suppression of tumor growth and reveals a metabolic adaptation axis with therapeutic implications.
N3-kethoxal: High-Resolution R-Loop and Genome Instability M
2026-04-24
Explore how N3-kethoxal enables precise mapping of R-loops and genomic instability, offering unique insights beyond standard RNA secondary structure probing. This article reveals technical advances and practical assay guidance for nucleic acid research.
Gefitinib (ZD1839): Optimizing EGFR Inhibition in Tumor Mode
2026-04-23
Gefitinib (ZD1839) delivers precise, reproducible inhibition of the EGFR signaling pathway in advanced cancer models, including patient-derived assembloids. This guide translates cutting-edge research into actionable protocols and troubleshooting strategies to accelerate translational oncology workflows.
c-Myc tag Peptide: Mechanistic Leverage in Translational Res
2026-04-23
Explore how the c-Myc tag Peptide empowers translational researchers to interrogate transcription factor regulation, optimize immunoassays, and bridge mechanistic insights from cancer to innate immunity. This article contextualizes APExBIO's c-Myc tag Peptide within the evolving landscape of displacement assays, highlights protocol parameters, and examines the translational challenges and opportunities in leveraging c-Myc for advanced research.
Forskolin as a Translational Engine: From cAMP Modulation to
2026-04-22
This thought-leadership article explores Forskolin’s evolving role as a direct adenylate cyclase activator and its transformative potential in translational research. Integrating mechanistic insight, protocol guidance, and real-world evidence, it provides a strategic roadmap for researchers advancing regenerative medicine, stem cell biology, and disease modeling. Drawing upon recent breakthroughs—such as the 6C cell culture paradigm for extending corneal epithelial proliferation—and leveraging APExBIO’s high-purity Forskolin, the article delineates actionable strategies and addresses both competitive and clinical landscapes. Unique in its synthesis, the piece offers forward-looking guidance while rigorously anchoring all numeric claims and workflow parameters.
Dabigatran Etexilate: Precision Anticoagulation for Advanced
2026-04-22
Explore the scientific foundations and practical advantages of Dabigatran etexilate as a direct thrombin inhibitor. This article uniquely dissects its anticoagulant mechanism and protocol optimization, offering distinct guidance for translational researchers.
TCAIM-Mediated OGDH Regulation: A New Layer in Mitochondrial
2026-04-21
Wang et al. (2025) reveal that the mitochondrial DNAJC co-chaperone TCAIM specifically binds and reduces a-ketoglutarate dehydrogenase (OGDH) protein levels, thereby modulating mitochondrial metabolism. This work uncovers an unrecognized post-translational mechanism that fine-tunes TCA cycle flux, with substantial implications for metabolic research and cellular energetics.
CKI 7 dihydrochloride: Precision Casein Kinase 1 Inhibitor W
2026-04-21
CKI 7 dihydrochloride empowers researchers to dissect Casein kinase 1 signaling with exceptional specificity in cancer and circadian rhythm studies. This guide delivers protocol enhancements and troubleshooting strategies, translating recent breakthroughs into actionable laboratory workflows.
CRISPR Screen Reveals F9 as a Key Regulator of Palbociclib-I
2026-04-20
A recent genome-wide CRISPR/Cas9 screen identifies coagulation factor IX (F9) as an essential mediator of senescence in breast cancer cells treated with CDK4/6 inhibitors like Palbociclib. These findings clarify resistance mechanisms and offer new avenues for optimizing antiproliferative strategies in cancer research.
AIBP-LRP2–HDL Axis Regulates CXCR4+ Capillary Expansion in I
2026-04-20
This study uncovers how AIBP-LRP2–mediated HDL uptake suppresses the expansion of CXCR4+ stemlike capillary endothelial cells, limiting collateral circulation in ischemic vascular disease. The findings reveal a two-phase mechanism for vascular remodeling, offering new insight into therapeutic targets for enhancing revascularization.
AZ505 SMYD2 Inhibitor: Protocols & Workflow for Epigenetic R
2026-04-19
Unlock precise epigenetic modulation with AZ505, a potent and selective SMYD2 inhibitor from APExBIO. This guide details optimized experimental workflows, troubleshooting strategies, and translational insights from recent fibrosis and cancer models, ensuring robust assay outcomes.
HyperScribe™ Poly (A) Tailing Kit: Optimizing RNA Stability
2026-04-18
The HyperScribe™ Poly (A) Tailing Kit empowers researchers to efficiently polyadenylate in vitro transcribed RNAs, boosting mRNA stability and translation efficiency for demanding applications such as transfection and functional genomics. Its robust workflow, anchored by E. coli Poly (A) Polymerase, is ideal for enhancing gene expression studies and troubleshooting persistent RNA instability.
Applied Use-Cases of Lisinopril Dihydrate in Hypertension Re
2026-04-17
Lisinopril dihydrate, a long-acting ACE inhibitor from APExBIO, drives reproducible advancements in hypertension and cardiovascular disease models. This article delivers actionable workflow tips and troubleshooting strategies for leveraging its high selectivity and purity in experimental research.
Phenacetin in hiPSC-Organoid PK: Protocols and Troubleshooti
2026-04-16
Explore how Phenacetin (N-(4-ethoxyphenyl)acetamide) enables high-fidelity pharmacokinetic studies using hiPSC-derived intestinal organoids. This guide delivers actionable protocol improvements, troubleshooting strategies, and data-driven insights for modern drug metabolism research.
Amiloride (MK-870): Precision Tools for Sodium Channel Resea
2026-04-15
Amiloride (MK-870) empowers researchers to dissect epithelial sodium channel and uPAR signaling with unrivaled specificity and reliability. This guide delivers actionable workflows, optimization strategies, and troubleshooting insights for sodium channel, endocytosis, and disease modeling experiments—drawing on proven protocols and comparative studies.
460 records 21/31 page Previous Next First page 上5页 2122232425 下5页 Last page